Related to Median Provides Sanofi with Image Interpretation Software for Phase II Lung Cancer Study

• mtm Labs and MetaSystems to Automate Cervical Cancer Biomarker Imaging
  
• GE Healthcare to Market Fujifilm Image-Analysis Platforms Worldwide
  
• Sanofi-Aventis to Pony Up $4B for Merck & Co.’s Half of the Firms’ Animal Health JV
  
• Nycomed Pads European Business with Acquisition of Generics from Sanofi-Aventis and Zentiva
  
• Researchers Cough Up New Evidence for Genetic Basis of Lung Cancer Risk in Smokers
  
• Multigene Signatures Correlate Better to In Vitro Chemosensitivity than Individual Gene Expression
  
• RainDance and CLC bio Partner to Provide Software for Targeted Resequencing
  
• PHD Diagnostics Develops Gene-Based Test to Predict Smokers’ Lung Cancer Risk
  
• Gene Variants That May Pose Greater Lung Cancer Risk for African Americans Identified
  
• Sanofi-Aventis Inks $539M Deal to Purchase Fovea
  
• Chilean Firm CeTeCancer to Evaluate Radient’s Lung Cancer IVD for Clinical Applications
  
• Researchers Identify Phosphorylation Signatures of Lung Cancer
  
• Comprehensive Sequencing of Lung Cancer and Melanoma Genomes Catalogs 55,000 Mutations
  
• Researchers Explain How Tobacco Carcinogen NNK Triggers Lung Tumors
  
• Researchers Uncover Mechanism of Tobacco Carcinogen
  
• Lilly, Merck & Co., and Pfizer Establish Asian Cancer Research Group Focused on Lung and Gastric Cancers
  
• Gene Expression Based Prognostic Signatures in Lung Cancer Not Ready for Clinical Use
  
• University of Cambridge Will Use IDBS Technology for Chemistry Research
  
• GenoLogics and CLC bio to Provide Data-Management and Analysis Solution for Next-Gen Sequencing
  
• Ambry Partners with SoftGenetics to Provide Extended Bioinformatics Services for Next-Gen Sequencing